Literature DB >> 8596686

Update on viral hepatitis in children.

L N Fishman1, M M Jonas, J E Lavine.   

Abstract

Recent discovery of the two major agents responsible for non-A, non-B hepatitis has led to rapid progress in the diagnosis and prevention of viral hepatitis. Newly implemented vaccine strategies against hepatitis A and hepatitis B are protecting children from infection, and new immunomodulatory therapy with interferon-alpha is being used to eradicate disease in patients chronically infected with hepatitis virus B or C.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596686     DOI: 10.1016/s0031-3955(05)70397-7

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  3 in total

1.  Epidemiological factors affecting hepatitis a seroprevalence in childhood in a developing country.

Authors:  Sevin Altınkaynak; Mukadder Ayşe Selimoğlu; Vildan Ertekin; Buket Kılıçaslan
Journal:  Eurasian J Med       Date:  2008-04

2.  Evaluation of an immunochromatographic assay for the detection of anti-hepatitis A virus IgM.

Authors:  Hyeok-Jin Lee; Hye Sook Jeong; Byung-Ki Cho; Mi-Jeong Ji; Ji-Ha Kim; An-Na Lee; Kyoung-Ryul Lee; Doo-Sung Cheon
Journal:  Virol J       Date:  2010-07-19       Impact factor: 4.099

3.  Antiviral agents in the critically ill child.

Authors:  Flor M Munoz
Journal:  Semin Pediatr Infect Dis       Date:  2005-11-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.